Arkolith/Insider Trading/VKTX/Form 4

Zante Greg

Chief Financial OfficerViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Jul 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$118K
Net Open-Market Flow
-$118K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 3, 2025Sell(S)4K$27.76$118K169K
Jul 2, 2025Grant(A)8K—$0173K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-093792) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML